In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Research Année : 2015

In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer

Résumé

The present work was designed to compare two mechanisms of cellular recognition based on Ab specificity: firstly, when the anti-HER2 mAb trastuzumab bridges target cells and cytotoxic lymphocytes armed with a Fc receptor (ADCC) and, secondly, when HER2 positive target cells are directly recognized by cytotoxic lymphocytes armed with a chimeric antigen receptor (CAR). To compare these two mechanisms, we used the same cellular effector (NK-92) and the same signaling domain (Fcí µí¼€RIí µí»¾). The NK-92 cytotoxic cell line was transfected with either a Fcí µí»¾RIIIa-Fcí µí¼€RIí µí»¾ (NK-92 CD16) or a trastuzumab-based scFv-Fcí µí¼€RIí µí»¾ chimeric receptor (NK-92 CAR). In vitro, the cytotoxic activity against HER2 positive target cells after indirect recognition by NK-92 CD16 was always inferior to that observed after direct recognition by NK-92 CAR. In contrast, and somehow unexpectedly, in vivo, adoptive transfer of NK-92 CD16 + trastuzumab but not of NK-92 CAR induced tumor regression. Analysis of the in vivo xenogeneic system suggested that the human CH2-CH3 IgG2 used as a spacer in our construct was able to interact with the FcR present at the cell surface of the few NSG-FcR+ remaining immune cells. This interaction, leading to blockage of the NK-92 CAR in the periphery of the engrafted tumor cells, stresses the critical role of the composition of the spacer domain.

Domaines

Cancer
Fichier principal
Vignette du fichier
Clemenceau_JImmunol.pdf (4.73 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01280823 , version 1 (01-03-2016)

Identifiants

Citer

Béatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, Régine Vivien, Raphaël Rousseau, et al.. In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer. Journal of Immunology Research, 2015, pp.482089. ⟨10.1155/2015/482089⟩. ⟨inserm-01280823⟩
71 Consultations
120 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More